Adding Modified Herpes Virus to Immunotherapy Shows Promise for Treating Advanced Melanoma – Newswise (press release)
|
Adding Modified Herpes Virus to Immunotherapy Shows Promise for Treating Advanced Melanoma
Newswise (press release) In a two-year UCLA-led study, nearly two-thirds of people with advanced melanoma responded positively to a treatment that combines the immunotherapy drug pembrolizumab with a herpes virus called talimogene laherpareovec, or T-VEC. Researchers led … |
